Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Haoxi Health Technology Limited Class A ( (HAO) ) just unveiled an update.
On October 13, 2025, Haoxi Health Technology Limited entered into a securities purchase agreement with non-U.S. investors to sell 5,217,391 Class A ordinary shares for approximately $1.2 million. The proceeds from this private placement will be used for working capital and general corporate purposes, potentially strengthening the company’s financial position and operational capabilities.
The most recent analyst rating on (HAO) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Haoxi Health Technology Limited Class A stock, see the HAO Stock Forecast page.
Spark’s Take on HAO Stock
According to Spark, TipRanks’ AI Analyst, HAO is a Neutral.
The overall score reflects a combination of strong valuation, with the stock appearing undervalued, and moderate financial performance, highlighted by revenue growth but hampered by cash flow issues. Technical analysis indicates a lack of strong momentum, contributing to the overall risk profile.
To see Spark’s full report on HAO stock, click here.
More about Haoxi Health Technology Limited Class A
Haoxi Health Technology Limited operates in the health technology industry, focusing on the development and provision of health-related technology solutions.
Average Trading Volume: 470,613
Technical Sentiment Signal: Sell
See more data about HAO stock on TipRanks’ Stock Analysis page.